Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.13% | 46.63% | -7.12% | -23.21% | 41.64% |
| Total Depreciation and Amortization | -5.71% | -10.26% | -4.88% | -8.89% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -124.00% | -91.20% | 879.31% | -67.05% | -16.19% |
| Change in Net Operating Assets | 62.17% | 1,082.61% | -108.01% | 409.70% | -460.19% |
| Cash from Operations | 59.60% | 138.82% | -700.00% | 113.77% | 10.32% |
| Capital Expenditure | 92.31% | -420.00% | -266.67% | 400.00% | 50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.31% | -420.00% | -127.78% | 1,900.00% | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 32.79% | -2.52% | -26.60% | 26.56% | 0.78% |
| Issuance of Common Stock | -49.59% | 107.55% | 123.37% | -76.54% | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00% | -- |
| Cash from Financing | -50.97% | 127.04% | 2.25% | -52.81% | 1,121.71% |
| Foreign Exchange rate Adjustments | 60.07% | -9.69% | -268.57% | -225.00% | 224.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.23% | 376.25% | -174.65% | 168.40% | 119.12% |
